Acute lymphoblastic leukaemia: open trials in Hong Kong

6 open trials have a site in Hong Kong. Registry data; only the trial team decides who can take part.

NCT06764238
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Trial Treatment · Phase 2/3 · Institute of Hematology & Blood Diseases Hospital, China
Hong Kong Children's Hospital, Hong Kong
Registry updated 2026-07-23
NCT07493408
Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML
Trial Treatment · Phase 2 · The University of Hong Kong
The University of Hong Kong, Hong Kong
Registry updated 2026-03-25
NCT07152041
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Trial Treatment · Phase 3 · Institute of Hematology & Blood Diseases Hospital, China
Hong Kong Children's Hospital, The Chinese University of Hong Kong, Hong Kong
Registry updated 2025-09-03
NCT06855810
Newly-diagnosed Pediatric T-cell ALL Protocol
Trial Treatment · Phase 2/3 · Institute of Hematology & Blood Diseases Hospital, China
Hong Kong Children's Hospital, Hong Kong
Registry updated 2025-08-26
NCT06882057
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Trial Treatment · Phase 2/3 · Institute of Hematology & Blood Diseases Hospital, China
Hong Kong Children's Hospital, Hong Kong
Registry updated 2025-08-26
NCT06866873
CD-19 CAR-T Cell for Pediatric ALL or Lymphoma
Trial Treatment · Hong Kong Children's Hospital
Hong Kong Children's Hospital, Hong Kong
Registry updated 2025-03-10

This page is not medical advice. Talk to your doctor before contacting a trial.

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol